Boston Scientific Corporation (BSX.F)

EUR 93.0

(4.49%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 35.13 Billion 32.47 Billion 32.23 Billion 30.77 Billion 30.56 Billion 20.99 Billion
Total Current Assets 6.51 Billion 5.76 Billion 6.31 Billion 6.69 Billion 4.69 Billion 4 Billion
Cash And Short Term Investments 865 Million 928 Million 1.92 Billion 1.73 Billion 217 Million 146 Million
Cash and Cash Equivalents 865 Million 928 Million 1.92 Billion 1.73 Billion 217 Million 146 Million
Short Term Investments - - - - - -
Net Receivables 2.22 Billion 1.97 Billion 1.77 Billion 1.53 Billion 1.93 Billion 1.6 Billion
Inventory 2.48 Billion 1.86 Billion 1.61 Billion 1.35 Billion 1.57 Billion 1.16 Billion
Other Current Assets 333 Million 350 Million 385 Million 410 Million 324 Million 922 Million
Total Non-Current Assets 28.62 Billion 26.71 Billion 25.91 Billion 24.08 Billion 25.86 Billion 16.99 Billion
Net PPE 3.29 Billion 2.83 Billion 2.68 Billion 2.54 Billion 2.41 Billion 1.78 Billion
Good Will And Intangible Assets 20.39 Billion 18.82 Billion 18.1 Billion 15.86 Billion 18.06 Billion 14.28 Billion
Good Will 14.38 Billion 12.92 Billion 11.98 Billion 9.95 Billion 10.17 Billion 7.91 Billion
Intangible Assets 6 Billion 5.9 Billion 6.12 Billion 5.91 Billion 7.88 Billion 6.37 Billion
Long-Term Investments 413 Million 407 Million 412 Million 918 Million 458 Million 424 Million
Tax Assets 3.84 Billion 3.94 Billion 4.14 Billion 4.21 Billion 4.19 Billion -424 Million
Other Non Current Assets 679 Million 707 Million 563 Million 545 Million 735 Million 932 Million
Other Assets 1 Million - 2 Million 3 Million - -2 Million
Total Liabilities 15.6 Billion 14.89 Billion 15.6 Billion 15.45 Billion 16.68 Billion 12.27 Billion
Total Current Liabilities 4.93 Billion 3.8 Billion 4.27 Billion 3.68 Billion 4.86 Billion 5.26 Billion
Account Payables 942 Million 862 Million 794 Million 513 Million 542 Million 349 Million
Tax Payables 220 Million 232 Million 209 Million 158 Million 265 Million -
Short Term Debt 531 Million 20 Million 261 Million 13 Million 1.41 Billion 2.25 Billion
Deferred Revenue 266 Million 220 Million 208 Million 138 Million 144 Million 2.24 Billion
Other Current Liabilities 3.19 Billion 2.7 Billion 3.01 Billion 3.01 Billion 2.76 Billion 411 Million
Total Non Current Liabilities 10.67 Billion 11.09 Billion 11.33 Billion 11.77 Billion 11.82 Billion 7.01 Billion
Long-Term Debt 8.96 Billion 9.26 Billion 9.19 Billion 9.52 Billion 8.86 Billion 4.77 Billion
Deferred Revenue Non Current 311 Million 289 Million 276 Million 257 Million 1.2 Billion 1.19 Billion
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.26 Billion 1.39 Billion 1.55 Billion 1.65 Billion 1.16 Billion 717 Million
Other Liabilities - - - - - -
Total Equity 19.52 Billion 17.57 Billion 16.62 Billion 15.32 Billion 13.87 Billion 8.72 Billion
Stock Holders Equity 19.28 Billion 17.57 Billion 16.62 Billion 15.32 Billion 13.87 Billion 8.72 Billion
Common Stock 17 Million 17 Million 17 Million 17 Million 16 Million 16 Million
Retained Earnings 819 Million -750 Million -1.39 Billion -2.37 Billion -2.25 Billion -6.95 Billion
Accumulated other comprehensive income 49 Million 269 Million 263 Million 207 Million 270 Million 33 Million
Common Stock Equity 19.28 Billion 17.57 Billion 16.62 Billion 15.32 Billion 13.87 Billion 8.72 Billion
Capital Lease Obligation 395 Million 352 Million 395 Million 408 Million 282 Million 6 Million
Total Investments 413 Million 407 Million 412 Million 918 Million 458 Million 424 Million
Total Debt 9.49 Billion 9.28 Billion 9.45 Billion 9.53 Billion 10.27 Billion 7.03 Billion
Net Debt 8.62 Billion 8.35 Billion 7.52 Billion 7.8 Billion 10.06 Billion 6.88 Billion

Balance Sheet Charts